Oppenheimer Increases Corteva (NYSE:CTVA) Price Target to $67.00

Corteva (NYSE:CTVA) had its target price hoisted by equities researchers at Oppenheimer from $62.00 to $67.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s target price indicates a potential upside of 25.16% from the stock’s previous close.

Other research analysts also recently issued research reports about the company. Mizuho reduced their price objective on Corteva from $59.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 1st. Royal Bank of Canada increased their price target on Corteva from $56.00 to $64.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. UBS Group cut their price target on Corteva from $65.00 to $64.00 and set a “buy” rating on the stock in a research note on Thursday, January 11th. BNP Paribas raised Corteva from an “underperform” rating to a “neutral” rating and set a $53.00 price target on the stock in a research note on Friday, February 2nd. Finally, Wells Fargo & Company increased their price target on Corteva from $54.00 to $65.00 and gave the company an “overweight” rating in a research note on Friday, February 2nd. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $63.29.

Corteva Stock Up 0.4 %

NYSE:CTVA opened at $53.53 on Tuesday. The stock’s fifty day moving average price is $55.19 and its two-hundred day moving average price is $50.24. Corteva has a 52-week low of $43.22 and a 52-week high of $63.06. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.90 and a current ratio of 1.56. The company has a market cap of $37.41 billion, a price-to-earnings ratio of 52.48, a P/E/G ratio of 1.40 and a beta of 0.77.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, February 1st. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.09. Corteva had a return on equity of 7.43% and a net margin of 4.27%. The firm had revenue of $3.71 billion for the quarter, compared to the consensus estimate of $3.54 billion. During the same quarter in the prior year, the business earned $0.16 EPS. On average, analysts anticipate that Corteva will post 2.86 EPS for the current year.

Hedge Funds Weigh In On Corteva

A number of large investors have recently modified their holdings of CTVA. CVA Family Office LLC acquired a new position in shares of Corteva during the 4th quarter worth about $25,000. BKM Wealth Management LLC acquired a new position in shares of Corteva during the 4th quarter worth about $27,000. Rise Advisors LLC boosted its stake in shares of Corteva by 2,522.2% during the 1st quarter. Rise Advisors LLC now owns 472 shares of the company’s stock worth $27,000 after buying an additional 454 shares during the last quarter. NewSquare Capital LLC boosted its stake in shares of Corteva by 70.6% during the 3rd quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock worth $28,000 after buying an additional 226 shares during the last quarter. Finally, Glass Jacobson Investment Advisors llc boosted its stake in shares of Corteva by 234.3% during the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 555 shares of the company’s stock worth $28,000 after buying an additional 389 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.